Taneli T. Tani
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-term outcome of photodynamic therapy with hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate for low-risk Basal Cell Carcinomas.
Journal: Photodiagnosis and photodynamic therapy
Published: November 01, 2024
Hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non-aggressive basal cell carcinomas: A non-sponsored, randomized, prospective and double-blinded trial.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 09, 2019
TERT promoter mutations in actinic keratosis before and after treatment.
Journal: International journal of cancer
Published: December 02, 2019
Long-term Outcome of Low-concentration Hexyl-5-aminolaevulinate Daylight Photodynamic Therapy for Treatment of Actinic Keratoses.
Journal: Acta dermato-venereologica
Published: June 16, 2016
Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses.
Journal: Acta dermato-venereologica
Published: January 26, 2016
Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial.
Journal: The British journal of dermatology
Published: May 27, 2015
Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
Journal: The British journal of dermatology
Published: July 21, 2014
Detecting field cancerization using a hyperspectral imaging system.
Journal: Lasers in surgery and medicine
Published: June 13, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026